2021 Global Space OMICS Market Size, Share and Trend Analysis Report: Advent of Fourth Generation Sequencing (In Situ Sequencing) Drives Growth

0

DUBLIN, August 06, 2021– (COMMERCIAL THREAD)–The Analysis report of the size, share and trends of the OMICS Spatial Market by Technology (Transcriptomics, Genomics, Proteomics), by Product, by Workflow, by Sample Type, by End Use, by Region and segment forecast, 2021-2028 “ report was added to ResearchAndMarkets.com offer.

The global space OMICS market size is expected to reach USD 484.22 million by 2028, growing at a CAGR of 10.00% from 2021 to 2028.

Startups and established players have continued to develop their products and launch new solutions, democratize their offerings beyond innovators and engage in mergers and acquisitions. The OMICS spatial field is derived from hyperplexed imagery; however, the main players have turned to the development of spatial transcriptomics solutions and products.

Rapid advances in the sequencing of tissues, genes and individual cells have led to the emergence of spatial genomic sequencing. OMICS spatial techniques provide quantitative data on gene expression and visualization of DNA and RNA mapping in tissue sections. The development of new technologies for space OMICS should create lucrative opportunities for the fields of translational research as well as diagnostics.

The space genomics technology segment is expected to grow at the fastest CAGR throughout the forecast period due to an increase in the launch of new platforms. The integration of high throughput solutions in transcriptomics, genomics and proteomics studies has made it possible to determine the link between the onset of the disease and the position of the genome.

The instruments product held the second largest share in 2020 due to the launch of new automated solutions for OMIC space studies. For example, in March 2021, Rebus Biosystems launched the new Rebus Esper spatial omics platform for a better understanding of tissue biology. The new integrated and automated instrument provides single-cell and monomolecular quantitative data with subcellular resolution and spatial context using advanced fluidics, imaging, chemistry and bioinformatics solutions.

The fresh frozen sample type is expected to experience significant growth over the forecast period. The advantages of fresh frozen samples in proteomics are validated by several research studies. For example, in March 2021, a study concluded that the filter-assisted sample preparation technique (FASP) produced 20% more protein identifications using fresh-frozen samples than samples fixed in formalin and included in paraffin (FFPE).

North America held the largest share in 2020 due to increased focus on translational research, increased government support for genomics and sequencing technologies, strong demand for personalized medicine and the presence of a large number of translational and university research organizations.

Highlights of the Space OMICS Market Report

  • By technology, spatial transcriptomics accounted for the largest share in 2020 and is expected to maintain its dominance throughout the forecast period, as most of the available products are based on mRNA analysis for positional information.

  • In terms of products, the consumables segment held the largest share of revenue in 2020 due to the frequent purchase of reagents and probes to operate the instruments.

  • On the basis of the workflow, the instrumental analysis segment dominated the market in 2020 due to the technological advancement and the launch of new products in the market.

  • The fresh frozen sample type is expected to grow at a lucrative CAGR from 2021 to 2028, as fresh frozen tissue preserves the native state of proteins and therefore is adopted in spatial proteomic analysis.

  • On the basis of end use, academic and translational research institutes dominated the market in 2020 due to an increase in biomedical research in academic universities

Market dynamics

Market driver analysis

  • Emerging potential of spatial analysis as a diagnostic tool for cancer

  • Advent of the fourth generation of sequencing (in situ sequencing)

  • Emerging players should strengthen market competitiveness

Analysis of market restrictions

Opportunity analysis

Analysis of market challenges

COVID-19 impact assessment

Analysis of market agreements and strategic alliances

Competitive landscape

  • 10x Genomics

  • Dovetail genomics

  • S2 Genomics, Inc.

  • NanoString Technologies, Inc.

  • Seven genomic bridges

  • PerkinElmer, Inc.

  • Bio-Techné

  • Danaher Company

  • IonPath, Inc.

  • Millennium Science Pty Ltd.

  • Akoya Biosciences, Inc.

  • Fluidigm Corporation

  • Diagénode Diagnostics

  • Biognosys SA

  • Rebus biosystems

  • Ultivue, Inc.

  • Vizgen Corp.

  • BioSpyder Technologies

  • Bruker

  • Brooks Automation, Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/pr644x

See the source version on businesswire.com: https://www.businesswire.com/news/home/20210806005204/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Director
[email protected]
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900


Source link

Leave A Reply

Your email address will not be published.